Head-To-Head Survey: LeMaitre Vascular (NASDAQ:LMAT) versus Anteris Technologies Global (NASDAQ:AVR)

Anteris Technologies Global (NASDAQ:AVR – Get Free Report) and LeMaitre Vascular (NASDAQ:LMAT – Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, institutional ownership, risk, valuation, analyst recommendations, dividends and earnings.

Earnings & Valuation

This table compares Anteris Technologies Global and LeMaitre Vascular”s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Anteris Technologies Global $1.91 million 276.65 -$94.14 million ($1.61) -3.37
LeMaitre Vascular $249.60 million 7.18 $57.73 million $2.75 28.47

LeMaitre Vascular has higher revenue and earnings than Anteris Technologies Global. Anteris Technologies Global is trading at a lower price-to-earnings ratio than LeMaitre Vascular, indicating that it is currently the more affordable of the two stocks.

Volatility and Risk

Anteris Technologies Global has a beta of 2.02, indicating that its stock price is 102% more volatile than the S&P 500. Comparatively, LeMaitre Vascular has a beta of 0.51, indicating that its stock price is 49% less volatile than the S&P 500.

Insider and Institutional Ownership

84.6% of LeMaitre Vascular shares are owned by institutional investors. 2.5% of Anteris Technologies Global shares are owned by insiders. Comparatively, 7.4% of LeMaitre Vascular shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Analyst Recommendations

This is a breakdown of recent ratings and price targets for Anteris Technologies Global and LeMaitre Vascular, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Anteris Technologies Global 1 1 3 0 2.40
LeMaitre Vascular 0 5 3 0 2.38

Anteris Technologies Global currently has a consensus price target of $13.75, suggesting a potential upside of 153.69%. LeMaitre Vascular has a consensus price target of $108.25, suggesting a potential upside of 38.27%. Given Anteris Technologies Global’s stronger consensus rating and higher probable upside, analysts clearly believe Anteris Technologies Global is more favorable than LeMaitre Vascular.

Profitability

This table compares Anteris Technologies Global and LeMaitre Vascular’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Anteris Technologies Global -4,637.48% -57.15% -50.73%
LeMaitre Vascular 23.51% 15.33% 9.97%

Summary

LeMaitre Vascular beats Anteris Technologies Global on 9 of the 13 factors compared between the two stocks.

About Anteris Technologies Global

(Get Free Report)

Anteris Technologies Global is a medical technology company focused on developing treatments for structural heart disease, particularly aortic valve conditions. Its work centers on transcatheter heart valve technology, which is designed to replace a damaged valve through a minimally invasive procedure. The company’s lead product is the DurAVR transcatheter heart valve. It is made using Anteris’ ADAPT tissue technology, which processes bovine pericardial tissue for use in medical devices. The valve is designed to resemble the structure and function of a healthy aortic valve.

About LeMaitre Vascular

(Get Free Report)

LeMaitre Vascular develops, manufactures and markets medical devices used primarily in the treatment of vascular disease. Its products support procedures performed by vascular surgeons and include vascular grafts, embolectomy catheters, carotid shunts, valvulotomes and other instruments used in vascular surgery. Founded in 1983 by vascular surgeon George LeMaitre, the company is headquartered in Burlington, Massachusetts. Its products are sold to hospitals and medical professionals around the world through a combination of direct sales and distributors.

Receive News & Ratings for Anteris Technologies Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anteris Technologies Global and related companies with MarketBeat.com's FREE daily email newsletter.